= Richard A. Morgan
{c}
Researcher in <immunotherapy>. <Richard A. Morgan> and collaborators reported a serious adverse event after engineered T-<cell> administration, documenting why target recognition must be assessed in healthy <tissues> as well as <tumours>.<Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 by Richard A. Morgan and others>[Title, author list and reported study]{ref}
Back to article page
